Cargando…
Emu Oil Reduces Small Intestinal Inflammation in the Absence of Clinical Improvement in a Rat Model of Indomethacin-Induced Enteropathy
Nonsteroidal-anti-inflammatory-drug (NSAID) enteropathy is characterized by small intestinal damage and ulceration. Emu Oil (EO) has previously been reported to reduce intestinal inflammation. Aim. We investigated EO for its potential to attenuate NSAID-enteropathy in rats. Methods. Male Sprague Daw...
Autores principales: | Abimosleh, Suzanne M., Tran, Cuong D., Howarth, Gordon S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612469/ https://www.ncbi.nlm.nih.gov/pubmed/23573127 http://dx.doi.org/10.1155/2013/429706 |
Ejemplares similares
-
Emu Oil and zinc monoglycerolate independently reduce disease severity in a rat model of ulcerative colitis
por: Mashtoub, Suzanne, et al.
Publicado: (2023) -
Glycomacropeptide Ameliorates Indomethacin-Induced Enteropathy in Rats by Modifying Intestinal Inflammation and Oxidative Stress
por: Cervantes-García, Daniel, et al.
Publicado: (2020) -
Gut Microbiota Mediates Protection Against Enteropathy Induced by Indomethacin
por: Xiao, Xue, et al.
Publicado: (2017) -
Emu oil offers protection in Crohn’s disease model in rats
por: Vemu, Bhaskar, et al.
Publicado: (2016) -
Preparation and evaluation of minoxidil foamable emu oil emulsion
por: Shatalebi, M.A., et al.
Publicado: (2014)